Global Antisera and Other Blood Fractions Market: Volume to Reach 707K Tons by 2030, Value Surging to $580.4B

IndexBox has just published a new report: World - Antisera And Other Blood Fractions - Market Analysis, Forecast, Size, Trends and Insights.

Driven by rising global demand, the market for antisera and blood fractions is expected to steadily grow over the next seven years. Forecasts suggest a CAGR of +1.7% in volume and +6.5% in value, resulting in a market volume of 707K tons and a value of $580.4B by 2030.

Market Forecast

Driven by increasing demand for antisera and other blood fractions worldwide, the market is expected to continue an upward consumption trend over the next seven years. Market performance is forecast to decelerate, expanding with an anticipated CAGR of +1.7% for the period from 2023 to 2030, which is projected to bring the market volume to 707K tons by the end of 2030.

In value terms, the market is forecast to increase with an anticipated CAGR of +6.5% for the period from 2023 to 2030, which is projected to bring the market value to $580.4B (in nominal wholesale prices) by the end of 2030.

Consumption

World Consumption of Antisera And Other Blood Fractions

In 2023, global antisera consumption expanded rapidly to 627K tons, surging by 12% against the year before. Over the period under review, consumption saw a prominent increase. Global consumption peaked in 2023 and is likely to see steady growth in the near future.

The global antisera market size surged to $374.5B in 2023, with an increase of 18% against the previous year. This figure reflects the total revenues of producers and importers (excluding logistics costs, retail marketing costs, and retailers' margins, which will be included in the final consumer price). In general, consumption continues to indicate a prominent increase. As a result, consumption reached the peak level of $382.9B. From 2022 to 2023, the growth of the global market remained at a somewhat lower figure.

Consumption By Country

China (198K tons) remains the largest antisera consuming country worldwide, accounting for 32% of total volume. Moreover, antisera consumption in China exceeded the figures recorded by the second-largest consumer, India (39K tons), fivefold. The third position in this ranking was taken by the United States (37K tons), with a 5.9% share.

From 2013 to 2023, the average annual growth rate of volume in China totaled +20.2%. In the other countries, the average annual rates were as follows: India (+8.9% per year) and the United States (+9.7% per year).

In value terms, the United States ($95.5B), Belgium ($81.6B) and Japan ($35B) were the countries with the highest levels of market value in 2023, with a combined 57% share of the global market.

In terms of the main consuming countries, Belgium, with a CAGR of +47.8%, saw the highest growth rate of market size over the period under review, while market for the other global leaders experienced more modest paces of growth.

The countries with the highest levels of antisera per capita consumption in 2023 were Belgium (3,123 kg per 1000 persons), Singapore (2,505 kg per 1000 persons) and Austria (1,445 kg per 1000 persons).

From 2013 to 2023, the biggest increases were recorded for Belgium (with a CAGR of +45.0%), while consumption for the other global leaders experienced more modest paces of growth.

Production

World Production of Antisera And Other Blood Fractions

In 2023, approx. 633K tons of antisera and other blood fractions were produced worldwide; picking up by 13% compared with the year before. Over the period under review, production saw a buoyant expansion. The pace of growth appeared the most rapid in 2021 when the production volume increased by 71% against the previous year. As a result, production reached the peak volume of 688K tons. From 2022 to 2023, global production growth failed to regain momentum.

In value terms, antisera production soared to $318.4B in 2023 estimated in export price. In general, production recorded a resilient expansion. The pace of growth appeared the most rapid in 2021 when the production volume increased by 60%. Over the period under review, global production attained the peak level in 2023 and is expected to retain growth in years to come.

Production By Country

China (193K tons) remains the largest antisera producing country worldwide, comprising approx. 30% of total volume. Moreover, antisera production in China exceeded the figures recorded by the second-largest producer, the United States (85K tons), twofold. The third position in this ranking was held by India (39K tons), with a 6.2% share.

In China, antisera production expanded at an average annual rate of +17.9% over the period from 2013-2023. In the other countries, the average annual rates were as follows: the United States (+6.6% per year) and India (+8.5% per year).

Imports

World Imports of Antisera And Other Blood Fractions

Global antisera imports reached 292K tons in 2023, surging by 2.7% compared with the previous year's figure. Overall, imports posted a strong increase. The growth pace was the most rapid in 2021 with an increase of 46% against the previous year. As a result, imports reached the peak of 333K tons. From 2022 to 2023, the growth of global imports remained at a somewhat lower figure.

In value terms, antisera imports surged to $268.9B in 2023. Over the period under review, imports enjoyed a buoyant increase. The most prominent rate of growth was recorded in 2017 when imports increased by 24%. Global imports peaked in 2023 and are likely to see gradual growth in years to come.

Imports By Country

Canada (28K tons), Austria (26K tons), Germany (23K tons), the United States (22K tons), the Netherlands (21K tons), France (17K tons), Italy (12K tons), China (12K tons), Colombia (12K tons), Switzerland (10K tons), Mexico (7.8K tons) and Australia (7.7K tons) represented roughly 68% of total imports in 2023. Belgium (7.1K tons) followed a long way behind the leaders.

From 2013 to 2023, the biggest increases were recorded for the Netherlands (with a CAGR of +30.7%), while purchases for the other global leaders experienced more modest paces of growth.

In value terms, the United States ($70.8B) constitutes the largest market for imported antisera and other blood fractions worldwide, comprising 26% of global imports. The second position in the ranking was taken by Germany ($31B), with a 12% share of global imports. It was followed by Belgium, with a 7.5% share.

In the United States, antisera imports increased at an average annual rate of +27.3% over the period from 2013-2023. In the other countries, the average annual rates were as follows: Germany (+7.3% per year) and Belgium (+26.3% per year).

Import Prices By Country

In 2023, the average antisera import price amounted to $920,190 per ton, picking up by 16% against the previous year. Over the period under review, import price indicated strong growth from 2013 to 2023: its price increased at an average annual rate of +5.6% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, antisera import price increased by +40.9% against 2021 indices. The most prominent rate of growth was recorded in 2022 an increase of 22% against the previous year. Over the period under review, average import prices hit record highs in 2023 and is likely to continue growth in the near future.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was the United States ($3,160,806 per ton), while Colombia ($57,946 per ton) was amongst the lowest.

From 2013 to 2023, the most notable rate of growth in terms of prices was attained by Belgium (+9.8%), while the other global leaders experienced more modest paces of growth.

Exports

World Exports of Antisera And Other Blood Fractions

In 2023, global antisera exports reached 298K tons, with an increase of 4.7% against 2022. Over the period under review, exports saw a resilient expansion. The pace of growth appeared the most rapid in 2021 with an increase of 60% against the previous year. As a result, the exports reached the peak of 455K tons. From 2022 to 2023, the growth of the global exports remained at a somewhat lower figure.

In value terms, antisera exports rose rapidly to $265.7B in 2023. In general, exports saw a strong increase. The most prominent rate of growth was recorded in 2020 with an increase of 28%. The global exports peaked in 2023 and are expected to retain growth in the near future.

Exports By Country

The United States represented the largest exporter of antisera and other blood fractions in the world, with the volume of exports accounting for 71K tons, which was near 24% of total exports in 2023. South Korea (22K tons) took a 7.4% share (based on physical terms) of total exports, which put it in second place, followed by Germany (7%), the UK (5.3%), Canada (5%), Spain (5%), Austria (4.9%) and Poland (4.9%). Ireland (12K tons), the Netherlands (11K tons), Singapore (8.8K tons), Belgium (7.2K tons) and Switzerland (6.8K tons) followed a long way behind the leaders.

Exports from the United States increased at an average annual rate of +7.4% from 2013 to 2023. At the same time, South Korea (+44.7%), Ireland (+33.7%), Poland (+31.3%), the Netherlands (+25.7%), Belgium (+21.4%), Canada (+16.4%), Singapore (+11.9%), Austria (+9.8%), Spain (+6.1%), Germany (+2.6%), Switzerland (+2.5%) and the UK (+1.1%) displayed positive paces of growth. Moreover, South Korea emerged as the fastest-growing exporter exported in the world, with a CAGR of +44.7% from 2013-2023. While the share of South Korea (+7 p.p.), Poland (+4.2 p.p.), Ireland (+3.6 p.p.), the Netherlands (+2.8 p.p.), Canada (+2.6 p.p.) and Belgium (+1.6 p.p.) increased significantly in terms of the global exports from 2013-2023, the share of Switzerland (-1.7 p.p.), the United States (-2.3 p.p.), Germany (-5.1 p.p.) and the UK (-5.3 p.p.) displayed negative dynamics. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Switzerland ($51.9B), Germany ($42.4B) and the United States ($36.4B) appeared to be the countries with the highest levels of exports in 2023, together accounting for 49% of global exports. Ireland, the Netherlands, Belgium, Austria, South Korea, the UK, Spain, Singapore, Poland and Canada lagged somewhat behind, together accounting for a further 39%.

South Korea, with a CAGR of +49.4%, recorded the highest growth rate of the value of exports, in terms of the main exporting countries over the period under review, while shipments for the other global leaders experienced more modest paces of growth.

Export Prices By Country

In 2023, the average antisera export price amounted to $890,165 per ton, picking up by 7.6% against the previous year. Overall, export price indicated measured growth from 2013 to 2023: its price increased at an average annual rate of +4.9% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, antisera export price increased by +75.1% against 2021 indices. The most prominent rate of growth was recorded in 2022 an increase of 63% against the previous year. Over the period under review, the average export prices hit record highs in 2023 and is likely to continue growth in years to come.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was Switzerland ($7,603,683 per ton), while Canada ($16,962 per ton) was amongst the lowest.

From 2013 to 2023, the most notable rate of growth in terms of prices was attained by Poland (+12.5%), while the other global leaders experienced more modest paces of growth.

Source: IndexBox Market Intelligence Platform